Glenmark Pharmaceuticals Limited

IN·SEBI (PIT + SAST)

Alivus Life Sciences Limited

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Browse the full record of transactions filed by Glenmark Pharmaceuticals Limited. Director active across 1 companies, notably Alivus Life Sciences Limited. Cumulatively, 2 disclosures have been recorded. The latest transaction was disclosed on 6 March 2024 — Sale. Regulator: SEBI (PIT + SAST). The full history is openly available.

Declarations2 total

Executives●SaleAAlivus Life Sciences Limited0SEBI

G

Glenmark Pharmaceuticals Limited

€447m67,389,944 shares@ €6.6383

Equity Shares

SEBI:7a6580285e4ab87778892b1e6940df5b0906ece1·6 Mar 2024

SEBI ↗

Executives●PledgeAAlivus Life Sciences Limited0SEBI

G

Glenmark Pharmaceuticals Limited

€67m9,609,571 shares@ €6.9563

Equity Shares

SEBI:a028b009998f2b6cd0e9f0078c26b6d97e983bed·21 Sept 2023

SEBI ↗

2 of 2 declarations